1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Patient characteristics and ROI (contrast-enhancing tumor area) derived diffusion metricsa
GBMMetastasisP Value (GBM vs Met)
No.2221
Sex (male/female)11/1112/9P = .82
Age (yr)65.6 (12.7)66.6 (11.8)P = .99
FA0.16 (0.04)0.11 (0.02)P < .001
OD0.43 (0.08)0.56 (0.10)P < .001
microFA0.29 (0.10)0.27 (0.10)P = .56
  • Note:—Met indicates Metastasis.
  • ↵a Data are given as mean and standard deviation (SD).